Healthcare -
Biotechnology - NASDAQ - US
$ 0.6581
-0.903 %
$ 83 M
Market Cap
-0.63
P/E
KPTI - COST OF REVENUE
Cost of Revenue KPTI - Karyopharm Therapeutics Inc.
4.94 M
LAST VALUE
20.53%
2 YEAR CAGR
-50.20%
5 YEAR CAGR
-16.06%
10 YEAR CAGR